Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
Edwards Lifesciences Corp (EW)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 1.6 | 1.5 | 1.8 | 1.6 | 1.8 | 2.2 | 1.9 | 2.1 |
| Asset turnover | 0.7 | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 |
| |
| Returns on Capital |
| ROIC (excluding intangibles) | 36.1% | 23.8% | 39.0% | 29.7% | 27.1% | 26.8% | 24.3% | 42.9% |
| ROIC (including intangibles) | 24.1% | 15.2% | 23.0% | 18.8% | 15.8% | 18.7% | 17.3% | 31.4% |
| ROE | 27.5% | 17.4% | 22.3% | 19.8% | 18.4% | 20.6% | 20.1% | 35.4% |
| ROA | 18.8% | 11.0% | 15.9% | 13.3% | 11.3% | 12.9% | 12.4% | 22.0% |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 40.6 | 42.8 | 45.6 | 44.8 | 46.6 | 45.0 | 46.2 | 45.3 |
| Days payables outstanding | 59.8 | 66.4 | 59.1 | 52.1 | 48.6 | 44.4 | 37.8 | 34.0 |
| Days inventory outstanding | 212.4 | 271.0 | 209.9 | 235.8 | 231.4 | 181.5 | 201.0 | 173.2 |
| Cash conversion cycle | 193.2 | 247.4 | 196.5 | 228.6 | 229.4 | 182.1 | 209.4 | 184.5 |
|